The existence of the upper common pathways is not well ‐established yet. This case describes atrioventricular nodal reentry tachycardia with persistent ventriculoatrial dissociation that proof of upper common pathway existence.
Background: Preoperative left atrial remodeling as Postoperative atrial
fibrillation (POAF) predisposing factors could be measured by left
atrial volume index (LAVI) and P-wave dispersion. Aim: This study aimed
to assess P-wave dispersion and LAVI as preoperative predictors of POAF
among patients who underwent Coronary Artery Bypass Graft (CABG).
Methods: An analytical retrospective cohort study was performed on
patients who underwent CABG. The P-wave dispersion and POAF were
evaluated based on documented ECG results. LAVI size was collected from
echocardiographic reports. Hazard ratios of P-wave dispersion and LAVI
for POAF were analyzed using Cox proportional hazard model. Result: A
total of 42 subjects (57±1 years) were included in this study. POAF
occurred in 28.6% of patients at a median of 2 days after CABG. P-wave
dispersion was significantly longer in patients in whom AF was developed
(53.03±3.82ms vs. 44.01±1.98ms, p:0.028), while LAVI difference was not
significant. The Cox proportional hazard model showed a significant
association between P-wave dispersion and risk of POAF (HR 1.05, CI95%,
1.001-1.103;p=0.048). There was no association between LAVI and risk of
POAF (HR1.003, CI 95%, 0.965-1.044;p=0.864). Conclusion: P-wave
dispersion is a predictor of POAF in patients who underwent CABG. Risk
stratification using P-wave dispersion enables clinicians to identify
high-risk patients before CABG surgery.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.